Molecular Innovations Toward Theranostics of Aggressive Prostate Cancer
Abstract
During the project, strategies for the preparation of new globular polymers (dendrimers) were introduced and methods for their rapid synthesis were pioneered. Both achievements address long-standing shortcomings of this field that have hindered translation to the clinic. Structure-activity relationships revealed design criteria for achieving high water solubility necessary for therapeutic application. Methods were surveyed for attaching varied functional groups including the therapeutic (through biolabile or stablelinkages) and imaging agent. This work led to the discovery of new hydrazone chemistry that offers broad application in drug/gene delivery. While the initially proposed multivalent therapeutics failed to recapitulate the activity of the lead compound, targeting prostate cancer cells with these constructs is now possible: a 60x increase in selectivity is seen. In aggregate, this opens opportunities for realizing new treatments.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2017
- Accession Number
- AD1048738
Entities
People
- Eric E Simanek
Organizations
- Texas Christian University